EMAIL THIS PAGE TO A FRIEND

PLoS pathogens

Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects.


PMID 23133371

Abstract

Viruses use a limited set of host pathways for infection. These pathways represent bona fide antiviral targets with low likelihood of viral resistance. We identified the salicylanilide niclosamide as a broad range antiviral agent targeting acidified endosomes. Niclosamide is approved for human use against helminthic infections, and has anti-neoplastic and antiviral effects. Its mode of action is unknown. Here, we show that niclosamide, which is a weak lipophilic acid inhibited infection with pH-dependent human rhinoviruses (HRV) and influenza virus. Structure-activity studies showed that antiviral efficacy and endolysosomal pH neutralization co-tracked, and acidification of the extracellular medium bypassed the virus entry block. Niclosamide did not affect the vacuolar H(+)-ATPase, but neutralized coated vesicles or synthetic liposomes, indicating a proton carrier mode-of-action independent of any protein target. This report demonstrates that physico-chemical interference with host pathways has broad range antiviral effects, and provides a proof of concept for the development of host-directed antivirals.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N3510
Niclosamide
C13H8Cl2N2O4
N0560000
Niclosamide (anhydrous), European Pharmacopoeia (EP) Reference Standard
C13H8Cl2N2O4